Skip to main content
. 2021 May 6;10(12):3886–3895. doi: 10.1002/cam4.3936

TABLE 4.

Treatment toxicities

IC+RT arm CCRT arm p‐value
n (%) n (%)
Grade 1 Grade 2 Grade 3 Grade 4 Grade 1 Grade 2 Grade 3 Grade 4
Hematological
Leukopenia 13 (13.1) 28 (28.3) 27 (27.3) 8 (8.1) 9 (9.1) 35 (35.4) 37 (37.4) 12 (12.1) 0.008
Neutropenia 5 (5.1) 12 (12.1) 13 (13.1) 44 (44.4) 8 (8.1) 20 (20.2) 17 (17.2) 42 (42.4) 0.098
Anemia 46 (46.5) 25 (25.3) 9 (9.1) 0 (0) 55 (55.6) 20 (20.2) 10 (10.1) 6 (6.1) 0.015
Thrombocytopenia 20 (20.2) 1 (1) 1 (1) 0 (0) 22 (22.2) 2 (2) 0 (0) 0 (0) 0.846
Nonhematological
Skin desquamation 55 (55.6) 22 (22.2) 3 (3) 45 (45.5) 27 (27.3) 7 (7.1) 0.371
Mucositis 41 (41.4) 38 (38.4) 5 (5.1) 47 (47.5) 31 (31.3) 6 (6.1) 0.751
Oral fungal infection 20 (20.2) 20(20.2) 1
Nausea and vomiting 16 (16.2) 13 (13.1) 1 (1) 20 (20.2) 13 (13.1) 1 (1) 0.899

Treatment toxicities were categorized and graded according to the NCI CTCAE v.3.0.

Abbreviations: CCRT, concurrent chemoradiotherapy; IC, induction chemotherapy; RT, radiotherapy.